Trials / Completed
CompletedNCT02982824
Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy
Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 6 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
Effect of oral magnesium sulfate (Mg) supplementation will be studied. Children with drug resistant idiopathic epilepsy following up in Pediatric Neurology Clinic, Ain Shams University, will be randomized to either Mg add-on treatment group or anti-epileptic drugs AEDs alone. Serum magnesium, seizure control and Intelligent quotation (IQ) will be done at base line and after 6 months of treatment.
Detailed description
The Aim of this work was to study the effect of Magnesium as add on therapy on clinical seizure control in drug resistant idiopathic epilepsy and IQ.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Magnesium | Oral magnesium |
| DRUG | Placebo - Concentrate | Placebo will be given |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-02-01
- Completion
- 2017-03-01
- First posted
- 2016-12-06
- Last updated
- 2017-05-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02982824. Inclusion in this directory is not an endorsement.